Using PRP and Cord Blood in Treatment of Covid -19

the Effect of PRP and Cord Blood in Improving the Symptoms of Covid-19

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT04393415

Enrollment

100

Registered

2020-05-19

Start date

2020-05-25

Completion date

2020-09-01

Last updated

2020-07-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Virus

Brief summary

covid - 19 is a critical viral infection that affects humans

Detailed description

Covid -19 pandemic started was declared in 2020

Interventions

COMBINATION_PRODUCTstem cells

giving stem cells to patients with covid - 19

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

SUPPORTIVE_CARE

Masking

DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender

ALL

Age

20 Years to 70 Years

Healthy volunteers

Inclusion criteria

* patients with positive covid -19 and has symptoms and isolated in the hospital

Exclusion criteria

* patients with negative test for covid -19

Design outcomes

Primary

Measure	Time frame	Description
the number of patients with positive covid 19 who will improve after receiving stem cells	2 weeks	patients with positive covid 19 who will improve after receiving stem cells

Countries

Egypt

Contacts

Primary ContactMahmoud Alalfy, PhD

mahmoudalalfy@ymail.com01002611058

Backup ContactMahmoud Alalfy, PhD

mahmoudalalfy@ymail.com0102611058

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026